Analysts Offer Predictions for McKesson Co.’s Q3 2025 Earnings (NYSE:MCK)

McKesson Co. (NYSE:MCKFree Report) – Equities research analysts at Leerink Partnrs cut their Q3 2025 earnings per share (EPS) estimates for McKesson in a research report issued to clients and investors on Monday, August 26th. Leerink Partnrs analyst M. Cherny now forecasts that the company will post earnings per share of $8.41 for the quarter, down from their previous estimate of $8.42. The consensus estimate for McKesson’s current full-year earnings is $31.68 per share. Leerink Partnrs also issued estimates for McKesson’s Q4 2025 earnings at $8.66 EPS.

McKesson (NYSE:MCKGet Free Report) last announced its quarterly earnings results on Wednesday, August 7th. The company reported $7.88 earnings per share for the quarter, topping the consensus estimate of $7.21 by $0.67. McKesson had a negative return on equity of 245.88% and a net margin of 0.97%. The company had revenue of $79.28 billion for the quarter, compared to the consensus estimate of $82.53 billion. During the same period last year, the firm earned $7.27 EPS. The firm’s revenue for the quarter was up 6.4% compared to the same quarter last year.

MCK has been the topic of a number of other reports. Barclays lifted their price objective on shares of McKesson from $596.00 to $616.00 and gave the company an “overweight” rating in a research report on Thursday, August 8th. Evercore ISI decreased their price target on shares of McKesson from $660.00 to $630.00 and set an “outperform” rating on the stock in a report on Thursday, August 8th. Mizuho lifted their target price on shares of McKesson from $540.00 to $570.00 and gave the company a “neutral” rating in a report on Thursday, August 8th. Argus lifted their price target on shares of McKesson from $570.00 to $670.00 and gave the stock a “buy” rating in a research note on Monday, June 24th. Finally, JPMorgan Chase & Co. increased their price objective on shares of McKesson from $656.00 to $661.00 and gave the stock an “overweight” rating in a research note on Wednesday, August 21st. Two analysts have rated the stock with a hold rating and fourteen have given a buy rating to the company’s stock. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus price target of $620.29.

View Our Latest Stock Report on MCK

McKesson Stock Up 1.1 %

Shares of McKesson stock opened at $556.65 on Tuesday. The firm has a market cap of $72.33 billion, a PE ratio of 24.87, a price-to-earnings-growth ratio of 1.46 and a beta of 0.45. McKesson has a 52 week low of $404.72 and a 52 week high of $637.51. The business’s fifty day simple moving average is $582.73 and its 200-day simple moving average is $555.48.

McKesson Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Tuesday, October 1st. Stockholders of record on Monday, September 2nd will be given a $0.71 dividend. The ex-dividend date is Friday, August 30th. This is a boost from McKesson’s previous quarterly dividend of $0.62. This represents a $2.84 annualized dividend and a dividend yield of 0.51%. McKesson’s payout ratio is presently 12.69%.

Insiders Place Their Bets

In related news, CEO Brian S. Tyler sold 3,753 shares of the firm’s stock in a transaction on Monday, August 5th. The stock was sold at an average price of $626.03, for a total transaction of $2,349,490.59. Following the sale, the chief executive officer now owns 82,339 shares of the company’s stock, valued at approximately $51,546,684.17. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. In other McKesson news, Director Maria Martinez sold 483 shares of the firm’s stock in a transaction on Friday, June 7th. The shares were sold at an average price of $585.88, for a total value of $282,980.04. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, CEO Brian S. Tyler sold 3,753 shares of the firm’s stock in a transaction that occurred on Monday, August 5th. The shares were sold at an average price of $626.03, for a total value of $2,349,490.59. Following the completion of the transaction, the chief executive officer now owns 82,339 shares in the company, valued at approximately $51,546,684.17. The disclosure for this sale can be found here. Insiders sold 17,574 shares of company stock worth $10,254,842 over the last three months. Insiders own 0.11% of the company’s stock.

Institutional Investors Weigh In On McKesson

Institutional investors have recently added to or reduced their stakes in the business. LRI Investments LLC bought a new position in McKesson during the 1st quarter worth approximately $28,000. Register Financial Advisors LLC purchased a new stake in McKesson in the first quarter worth $29,000. Sachetta LLC bought a new stake in McKesson in the fourth quarter valued at $27,000. Newbridge Financial Services Group Inc. increased its position in McKesson by 333.3% during the 1st quarter. Newbridge Financial Services Group Inc. now owns 65 shares of the company’s stock valued at $35,000 after purchasing an additional 50 shares during the period. Finally, Richardson Financial Services Inc. bought a new stake in shares of McKesson during the 4th quarter valued at about $31,000. 85.07% of the stock is owned by hedge funds and other institutional investors.

About McKesson

(Get Free Report)

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products.

See Also

Earnings History and Estimates for McKesson (NYSE:MCK)

Receive News & Ratings for McKesson Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for McKesson and related companies with MarketBeat.com's FREE daily email newsletter.